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Abstract
Despite recent advances in the development of biomaterials intended to replace natural bone grafts
for the regeneration of large, clinically relevant defects, most synthetic solutions that are currently
applied in the clinic are still inferior to natural bone grafts with regard to regenerative potential
and are limited to non-weight-bearing applications. From a materials science perspective, we always
face the conundrum of the preservation of bioactivity of calcium phosphate ceramics in spite of better
mechanical and handling properties and processability of polymers. Composites have long been
investigated as a method to marry these critical properties for the successful regeneration of bone
and, indeed, have shown a significant improvement when used in combination with cells or growth
factors. However, when looking at this approach from a clinical and regulatory perspective, the use
of cells or biologicals prolongs the path of new treatments from the bench to the bedside. Applying
’smart’ synthetic materials alone poses the fascinating challenge of instructing tissue regeneration
in situ, thereby tremendously facilitating clinical translation. In the journey to make this possible,
and with the aim of adding up the advantages of different biomaterials, combinations of fabrication
technologies arise as a new strategy for generating instructive three-dimensional (3D) constructs for
bone regeneration. Here we provide a review of recent technologies and approaches to create such
constructs and give our perspective on how combinations of technologies and materials can help in
obtaining more functional bone regeneration. Copyright © 2013 John Wiley & Sons, Ltd.
Received 10 December 2012; Revised 12 February 2013; Accepted 4 April 2013
Keywords bone; regenerative medicine; scaffolds; rapid prototyping; electrospinning; injectable
1. Introduction
Bone is probably one of the best examples of tissues for
which an increasing need exists for regenerative strate-
gies, as a consequence of population ageing. To realize
the extent and prevalence of bone-related diseases and
disorders, it is interesting to note that 2000–2010 was
appointed as a Bone and Joint Decade by the World
Health Organization (Cambron and King, 2006). Musculo-
skeletal conditions are the most common causes of severe
long-term pain and physical disability, and account for half
of all chronic conditions in people aged over 50years in
developed countries. In 1998, in the USA, about 220 000
cases of spinal fusion requiring a bone graft were
performed. Each year, approximately 170 000 fractures
do not heal and are diagnosed as ’non-unions’, requiring
some form of bone graft substitute (Chen et al., 2003).
While autologous bone grafts are still considered the best
solution when it comes to treatment of large, critical-sized
bone defects, the limited availability is becoming an
increasingly important problem as the need for regener-
ative strategies expands, in addition to other concerns,
including donor site morbidity, need for an additional
surgery, etc. Other natural bone grafts are widely used
too, but their performance is often inferior to that of
autografts as a consequence of treatments to avoid
disease transmission to and immunogenic response by
the recipients.
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As an alternative to natural bone grafts, various tissue-
engineering approaches have been developed in the past
25years in an attempt to mimic the role of natural bone
grafts as closely as possible. Tissue-engineering approaches
for bone repair and regeneration are based on stimulating
bone formation through the use of growth factors and/or
cells in combination with a biomaterial scaffold. Bone mor-
phogenetic proteins (BMPs), for example, were discovered
and defined as compounds present in demineralized bone
matrix (DBM) that act as sole inducers of de novo bone
formation (Urist, 1965). Owing to their osteoinductive
potential, two BMP family members have found their way
to the clinic, where they are used for enhancing non-unions
of long bones, spinal fusion, craniomaxillofacial disease
and for periodontal and dental indications, as reviewed else-
where (Kirker-Head, 2000). The advances in recombinant
DNA technology have also allowed for the availability of
BMPs readily and in large quantities. BMP therapy is, how-
ever, based on the application of supraphysiological concen-
trations and is therefore accompanied by the risk of, for
example, heterotopic bone formation (Haidar et al., 2009).
FDA approval for the application of BMP-2 and BMP-7, there-
fore, comes with restrictions. In the conventional tissue-
engineering cell-based approach, cells are obtained from
the patient, expanded on two-dimensional (2D) surfaces
such as plates or flasks, seeded on a three-dimensional
(3D) scaffold, to finally be implanted into the patient for re-
pair and regeneration.While somewhat contradictory results
exist regarding the (pre)clinical successes of cell-based
tissue-engineering constructs (Meijer et al., 2007), no prod-
ucts have yet reached the clinic. One of the reasons for this
may also be the high costs associated with the production
and storage of cell-based tissue-engineered constructs.
While a number of synthetic materials had been used
for treating bone defects long before tissue-engineered
constructs were developed, they have never really been
considered a true alternative to natural bone grafts. An
important reason is that the majority of these bone graft
substitutes were inferior to their natural counterparts in
terms of biological response. While most synthetic bone
graft substitutes have been shown to be biocompatible
and osteoconductive, they are generally considered non-
osteoinductive, which makes them inferior in the treat-
ment of large, critical-sized defects as compared to natural
bone grafts and constructs containing osteoinductive
growth factors. Osteoinduction is the process of differenti-
ation of undifferentiated cells into the osteogenic lineage
(Friedenstein, 1968), followed by bone formation, and is
believed to be the key element for closing large, critical-
sized bone defects. Nevertheless, the idea of using synthetic
biomaterials for the treatment of large bone defects has
been revisited in the past decade, as they are relatively inex-
pensive and available in large quantities off-the-shelf. Much
effort has also been put into improving their biological
performance and a number of groups have reported
biomaterials, generally calcium phosphate ceramics, with
intrinsic osteoinductivity (Barradas et al., 2011). Intrinsi-
cally osteoinductivematerials are an example of ’instructive’
or ’smart’ synthetic materials, owing to their ability, directly
or indirectly, to trigger osteogenic differentiation of non-
bony cells in the heterotopic environment, followed by de
novo bone formation. While indications and hypotheses
exist identifying surface features, including microporosity
and grain size as well as dissolution/reprecipitation events
occurring on the surface, as properties responsible for the
osteoinductive potential of synthetic biomaterials, the exact
biological mechanism behind osteoinduction is still incom-
pletely understood (Barradas et al., 2011). An important
reason is that the level of control over the properties of
osteoinductive calcium phosphate ceramics is limited and
dependent on processing parameters. Efforts to design
’smart’ biomaterials while retaining their synthetic charac-
ter are growing, as is illustrated by elegant work on control
of cell fate by tailoring surface micro- and nanopatterning
(Dalby et al., 2007; Kilian et al., 2010; McBeath et al.,
2004;McMurray et al., 2011; Unadkat et al., 2011),mechan-
ical properties and chemical surface functionalization of the
materials (Huebsch et al., 2010; Kshitiz et al., 2012; Lutolf
and Blau, 2009; Villa-Diaz et al., 2010). However, most
methods to design and engineer surface properties of
solid materials are solely applicable to 2D substrates and
limited to polymers. Functionalization of hydrogels can
be performed within an intrinsic 3D environment (Benoit
et al., 2008; DeForest et al., 2009; Kobel and Lutolf, 2012;
Luo and Shoichet, 2004). However, successful regeneration
of large bone defects requires functional 3D materials,
ideally able to withstand mechanical loading. Therefore, a
challenging step remains to be taken to optimally employ
advances in surface control to significantly improve the
biological performance of synthetic bone graft substitutes.
Indeed, while desired biological performance is a prerequi-
site for the success of a material as a bone graft substitute,
other requirements also need to be met. As previously men-
tioned, mechanical properties are important, particularly
when it comes to load-bearing applications. In that respect,
not only the type of biomaterial but also its structural prop-
erties (e.g. porosity, interconnectivity) when processed to
create a 3D scaffold play an important role. Handling prop-
erties, such as injectability and ease of surgical manipula-
tion, constitute another issue that needs to be considered
in specific applications.
While many excellent reviews exist on different types of
biomaterials used in bone-regenerative strategies (Damien
and Parsons, 1991; Dinopoulos et al., 2012), the focus of
the current paper is to review recently undertaken
approaches to develop, employ and combine materials
and fabrication technologies in order to provide plug-
and-play systems able to meet the specific requirements
of an application in both basic research and clinical use.
2. Building 3D constructs for bone
regeneration
Calcium phosphate ceramics (Yuan et al., 2010), such as
hydroxyapatite (HA) (Deville et al., 2006; Yoshikawa et al.,
2009), tricalcium phosphate (TCP) (Dong et al., 2002;
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Fu et al., 2000; Niedhart et al., 2001) and biphasic calcium
phosphate (BCP), consisting of HA and TCP (Legeros et al.,
2003), have a long history of use in bone-regenerative strat-
egies, owing to their similarity in chemical composition to
bone mineral and related bioactivity in terms of
osteoconductivity and, sometimes, even osteoinductivity
(Barradas et al., 2011; Damien and Parsons, 1991). An
important disadvantage of most calcium phosphate
ceramics is their intrinsic brittleness (Zimmermann and
Moghaddam, 2011), limiting their use to non-load bearing
or supported applications.With the rationale that in natural
bone the organic component (predominantly collagen) is
responsible for excellent mechanical properties, it is not
surprising that many strategies focus on a combination of
calcium phosphate ceramics and natural or synthetic poly-
mers in an attempt to develop bone graft substitutes with
improved mechanical properties, without compromising
bioactivity. Combinations of calcium phosphate ceramics
with metals that are widely used in orthopaedics, such as
titanium and its alloys, is another approach to improve
mechanical properties. However, considering the non-
degradability of most metals, this possibility is less explored
in the context of tissue regeneration. Apart from the intrin-
sic mechanical properties of different material types, the
way they are built into 3D constructs and consequent prop-
erties of, for example, the resulting porous structure, will
greatly determine themechanical properties of the resulting
cellular solid.
Calcium phosphate ceramics are usually produced as
(porous) granules, beads or scaffolds with a defined
shape, which allows for implantation into confined defects
using conventional surgical procedures. With an increas-
ing need to perform minimally invasive surgical proce-
dures, it is necessary to improve the handling properties
of ceramics, making them mouldable or injectable, which
can also be achieved by combining ceramic particles with
polymers that enable the desired handling. In the next
section we discuss scaffolding techniques that are used to
build 3D constructs for bone regeneration in an attempt to
control mechanical and handling properties and biological
performance.
3. Conventional scaffold fabrication
technologies
First-generation polymeric scaffolds used in regenerative
strategies were fabricated using conventional methods such
as solvent casting (Mikos et al.,1993), gas foaming (Mooney
et al., 1996), freeze drying (Schoof et al., 2001) and partic-
ulate leaching (Claase et al., 2003). For ceramics andmetals
powder metallurgical processing technologies were used,
including (polymer) replica techniques (Colombo, 2006;
Luyten et al., 2009; Ramay and Zhang, 2003), direct
foaming of a liquid slurry and burning out of fugitive
porogens (Chen et al., 2006; Colombo, 2006; Padilla et al.,
2005), followed by calcination and sintering. Although
these techniques are very useful for fabricating scaffolds,
they suffer from some drawbacks. While it is possible to
control pore size and shape by altering processing condi-
tions, fabrication of fully interconnected scaffolds remains
a challenge. Low interconnectivity leads to tortuous paths
in the scaffolds, which influence infiltration of the scaffold
by cells and tissue and their survival. Combinations of the
conventional technologies with template porogens of highly
controlled dimensions at the micro- and nanoscale have
improved pore interconnectivity. Inverted colloidal crystal
(ICC), in particular, was used to fabricate poly(lactic-
co-glygolic acid) (PLGA) 3D scaffoldswith an interconnected
pore architecture mimicking that of cancellous bone
(Cuddihy and Kotov, 2008). These scaffolds were also
shown to be useful in setting the first steps to recreate an
in vitro model of bone marrow (Nichols et al., 2009) and,
more recently, the combination of ICC with layer-by-layer
approach added to versatility in the fabrication of scaffolds
with enhanced (bio)functionalities (Andres et al., 2012).
However, pore tortuosity and strut fragility are critical
characteristics that need to be improved when aiming to
build scaffolds able to regenerate vascularized bone tissue
and with mechanical properties able to sustain dynamic
loading. In order to overcome the limitations associated
with conventional scaffold fabrication technologies, rapid
prototyping (RP) techniques have been employed.
4. Rapid prototyping
In the past 25–30years, several RP or solid freeform fabrica-
tion (SFF) systems were developed and commercialized for
the manufacture of prototypes used in various industries,
such as the aerospace, automotive and consumer
industries, in electrical and electronic products and in
biomedical applications (Chua et al., 2010). As the name
suggests, these techniques fabricate parts or prototypes
without the use of moulds. Parts are built layer-by-layer by
additive manufacturing through computer-aided design/
computer-aided manufacturing (CAD/CAM), which is
opposite to the usual practice of removing materials during
conventional fabrication processes. Additionally, RP can be
used to fabricate controlled structures that can later be used
as negative replicas or sacrificial moulds to fabricate scaf-
folds. In the last decade, RP technologies have been widely
used to fabricate 3D scaffolds for a number of applications,
due to various advantages. RP technologies offer more con-
trol compared to conventional technologies and can repro-
ducibly fabricate parts. Since the fabrication is performed
layer by layer, it is also possible to modify properties of indi-
vidual layers to obtain complex 3D structures. The possibil-
ity of tuning various aspects of scaffold properties, such as
porosity, interconnectivity, mechanical strength and degra-
dation, makes RP a powerful tool for scaffold production
and allows the fabrication of customized scaffolds with
properties that match a specific application (Hollister,
2005; Lin et al., 2004). RP technologies can also be inte-
grated with standard medical imaging processes, such as
computed tomography (CT) or magnetic resonance imaging
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(MRI) to create customized implants for patients (Figure 1),
which in some cases has proved to be effective in the recon-
struction of complex and large bone segments (Hutmacher
et al., 2004; Li et al., 2011).
RP technologies are predominantly used to build poly-
meric scaffolds; nevertheless, ceramics, metals and various
composites have also been processed into 3D constructs
for bone regeneration using RP techniques. Based on the
type of technology used, RP systems can be classified into
extrusion-, laser- and printing-based systems. Figure 2
displays a schematic overview of the different types of RP
systems (Hollister, 2005). The use of RP technologies and
the control they provide over parameters such as pore size
and shape enabled the creation of different scaffolds, in
which the mechanical properties could be modulated to
match those of a particular tissue to be repaired (Moroni
et al., 2006b).
The advantages of extrusion-based systems include the
processing of different material types alone or in the same
construct, no trapping of unused materials inside the final
construct and only temporary heating of raw materials at
elevated temperatures, which limits the negative effects
of long-term heating, such as thermal degradation.
Among extrusion-based systems, fused deposition model-
ling (FDM) is a very popular technique for fabricating
scaffolds. FDM involves the extrusion of the material in a
layered way to create scaffolds. While in the past it was
only possible to use few non-resorbable polymeric mate-
rials, e.g. acrylonitrile butadiene styrene, polyamide,
current FDM systems can process polymers, such as poly
(e-caprolactone) (PCL), poly(L-lactic acid) (PLLA) and
PLGA, that are widely used in biomedical applications.
Extensive work on the fabrication, characterization and
testing of 3D polymeric scaffolds from PCL and composites
such as PCL/TCP and PCL/HA for bone regeneration and
tissue engineering has been performed by Hutmacher
and co-workers (Hutmacher et al., 2001; Lam et al.,
2009; Schantz et al., 2005; Yefang et al., 2007; Zhou
et al., 2007). These authors have shown, for example, that
co-culture of endothelial cells and bone marrow-derived
fibroblasts on such 3D scaffolds led to enhanced cell
differentiation (Choong et al., 2006). Recently, it has been
demonstrated that PCL–TCP scaffold, produced using FDM
in combination with BMP-7 infusion, resulted in faster
regeneration of a critical-sized long bone defect in sheep,
with improved mechanical properties and remodelling of
Figure 1. Development of patient-specific bone graft substitutes by combining medical imaging, computational modelling and rapid
prototyping (RP). CT scan data of the patient’s bone defect (A) are used to generate a computer-based 3D model (B). This model is
then imported into RP system software to be ‘sliced’ into thin horizontal layers, with the tool path specified for each layer (C). The
‘sliced’ data are used to instruct the RPmachine (D) to build a scaffold (E) layer by layer, based on the actual shape of the computermodel
(C). RP technology produces excellent templates for the treatment of intricate bone defects (A, F). Custom-made constructs (G, see arrows)
exactly follow the complex shaped 3D contour of the skull. Reprinted with permission from Hutmacher et al. (2004)
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the regenerated bone tissue compared to autograft and
scaffolds used alone or seeded with bone marrow-derived
mesenchymal stromal cells (MSCs) (Reichert et al., 2012).
Although the performance of scaffolds alone was inferior
to that of scaffolds loaded with the growth factor, the
authors suggested that scaffolds contributed to successful
bone healing, through their mechanical properties sufficient
for weight bearing as well as the capacity to locally deliver
BMP-7 necessary for osteoinduction. Furthermore, scaffolds
without cells or growth factors were able to provoke consid-
erable bone ingrowth across the defect, which was not
observed in empty control defects. 3D fibre deposition
(3DF), which is a variant of FDM, has been used for the fab-
rication of scaffolds for bone and cartilage regeneration.
Figure 2. Different solid freeform fabrication systems categorized by processing technique. (A, B) Laser-based processing systems
include the stereolithography system, which photopolyermerizes a liquid (A) and the SLS systems, which sinter powdered material
(B); in each system, material is swept over a build platform that is lowered for each layer. (C, D) Printing-based systems include 3D
printing (C) and a wax printing machine (D); 3DP prints a chemical binder onto a powder bed. The wax-based system prints two types
of wax material in sequence. (E, F) Nozzle-based systems: fused deposition modeling prints a thin filament of material that is heated
through a nozzle (E). The Bioplotter prints materials that are processed either thermally or chemically (F). Reprinted with permission
from Hollister (2005)
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The 3DF process can be done by extrudingmolten polymers,
hydrogels or pastes in the form of a fibre. In an attempt to
control mechanical properties and to improve bioactivity
by tailoring macrostructure, scaffolds were fabricated from
polymers (Gloria et al., 2012; Moroni et al., 2008; Sobral
et al., 2011; Woodfield et al., 2004), metals (Li et al.,
2005a; Li et al., 2010), calcium phosphate ceramics
(Miranda et al., 2006) and polymer–ceramic composites
(Nandakumar et al., 2013a).
Techniques based on lasers include stereolithography
(SLA) and selective laser sintering (SLS). In SLA, UV or
visible light lasers are vector-scanned on a bath that
contains a photopolymerizable resin. The laser cures the
resin at specific areas where it is illuminated and creates
a solid layer that attaches to the support platform. This
process is repeated layer by layer to create a 3D structure
based on a CAD model. Excess resin is washed out and
the sample may be cured in a UV oven if needed
(Melchels et al., 2010b). SLA can achieve resolutions of
around 20 mm (other RP techniques are in the range
50–200 mm) and it is relatively easy to remove the support
materials used during fabrication, making this technique
potentially applicable in trauma surgery for fracture fixation
devices, parts of hip- and knee implants and as nerve
guidance channels and prostheses (Melchels et al., 2010b).
Nevertheless, the biggest limitation of SLA is poor availabil-
ity of photopolymerizable biomaterial resins with the
desired properties (Melchels et al., 2010b; Yang et al.,
2002). Therefore, SLA was primarily used for creating 3D
models that improved the spatial understanding of the
anatomy and physiology and assisted surgeons by reducing
the time and risk involved in surgery (Binder et al., 2000;
Sarment et al., 2003). In the last decade biodegradable resins
based on poly(propylene fumarate) (PPF) (Cooke et al.,
2003), trimethylene carbonate (TMC) and e-caprolactone
(CL) (Lee et al., 2008;Matsuda andMizutani, 2002;Matsuda
et al., 2000), D,L-lactide (DLLA) (Jansen et al., 2009;Melchels
et al., 2009) and photo-curing modified natural polymers
(Qiu et al., 2009; Schuster et al., 2009; Smeds et al., 1999;
Zimmermann et al., 2002) have been synthesized and used
to fabricate 3D scaffolds by SLA for biomedical applications.
Initial studieswith PDLLA SLA scaffolds showed improved cell
distribution, while PPF SLA scaffolds were shown to support a
more robust and rapid differentiation of rat MSCs into the
osteogenic lineage when compared to similar scaffolds fabri-
cated by conventional porogen leaching, whichwas attributed
to enhanced stiffness and improved scaffold permeability
(Kim et al., 2011; Melchels et al., 2010a). An improvement of
SLA is two-photonpolymerization (2PP), inwhich a photosen-
sitive resin is polymerized by a laser beam (Ovsianikov and
Chichkov, 2012; Ovsianikov et al., 2007). The resolution of
this RP technology can reach the sub-micron scale. Although
new biomaterials with satisfactory biocompatibility have been
synthesized and the speed of fabrication has improved, the
resins that are readily available for 2PP need to prove their
biocompatibility in vivo, and the production speed to reach
clinically relevant dimensions also needs to be further
improved. Therefore, applications in the field of bone regener-
ation are still too premature with this technology.
SLS works in a manner similar to SLA, with the differ-
ence that a powder bed is sintered selectively using a laser.
The interaction of the material with the laser causes an
increase in the temperature of the material and sintering
occurs at temperatures slightly higher than glass transition
temperature, which fuses the particles. Subsequent layers
are fabricated on top of existing layers and new powder is
deposited using a roller. Similarly to SLA, SLS can poten-
tially be used for the production of customized implants
for the treatment of large bone defects caused by trauma,
tumour removal and similar events. Using SLS, polymers
such as PCL, PLLA, poly(ether ether ketone) (PEEK) and
poly(hydroxybutyrate-co-hydroxyvalerate) have been com-
bined with ceramics to create composite bioactive scaffolds
for bone regeneration, and showed enhanced osteoblast
proliferation and differentiation when compared to similar
scaffolds without the inclusion of ceramics (Antonov et al.,
2004; Duan et al., 2010; Tan et al., 2003; von Wilmowsky
et al., 2008; Williams et al., 2005). PCL SLS scaffolds also
showed successful initial tissue formationwhen seededwith
BMP-7-transduced fibroblasts after subcutaneous implanta-
tion (Williams et al., 2005). Although with SLS it is possible
to significantly increase the percentage of ceramic particles
(> 50%) into the polymeric phase of composites, the final
results are still not at par with what is expected. Recently,
Lohfeld et al. (2012) showed that the introduction of TCP
in PCL SLS scaffolds resulted in lower bone tissue formation
in a critical-sized defect in vivo compared to PCL, likely due
to the mismatch between the PCL and the TCP particle size
and to the resulting inferior mechanical properties at
high TCP concentrations. High accuracy, good mechanical
strength and a broad choice of materials are some of the
advantages of SLS, while high processing temperatures, dif-
ficulty in removing entrapped materials and the inability to
process hydrogels still remain current drawbacks (Melchels
et al., 2010b; Yang et al., 2002). For metals, electrical beam
sintering, a method similar to SLS was used to directly build
3D scaffolds (Hollister et al., 2005; Mazumder et al., 2000).
3D printing (3DP) has the advantage of being able to
fabricate 3D structures at ambient temperatures (Sachs
et al., 1994). Fresh powder is deposited on a stage, onto
which a binder solution is subsequently printed by an
inkjet head, following a specific CAM pattern. After a layer
is complete, the process is continued in a layer-by-layer
manner similarly to the previously described RP technolo-
gies. Weak bonding between layers and the difficulty of
removing entrapped materials that could potentially lead
to the incorporation of the binder material in the final
scaffold, causing toxicity problems, are some disadvan-
tages of this method (Peltola et al., 2008; Yang et al.,
2002). 3DP was used for fabricating ceramic moulds to
cast materials needed for orthopaedic implants (Curodeau
et al., 2000) and a combination of PLGA, PLA and TCP was
used to fabricate scaffold constructs for the repair of artic-
ular cartilage (Sherwood et al., 2002). PLGA 3DP scaffolds
were shown to support osteoconduction when implanted
in orthotopic locations in a rabbit model (Ge et al.,
2009). Although these studies reported promising results
for 3DP scaffolds in musculoskeletal applications, in order
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to completely overcome biocompatibility issues posed by
using organic solvents, such as chloroform as binders,
calcium phosphate-based ceramics have been directly fabri-
cated into scaffolds for bone regeneration using biocompat-
ible or water-soluble polymeric binders that can be removed
during sintering at high temperatures (Khalyfa et al., 2007;
Leukers et al., 2005; Seitz et al., 2005). 3D printing was also
applied to directly deposit calcium and magnesium phos-
phate cements at ambient temperatures (Gbureck et al.,
2007; Klammert et al., 2010). Such scaffolds were shown
to be suitable as drug delivery vehicles (Gbureck et al.,
2007), as well as for vertical bone augmentation in a
calvarial model in rabbits (Torres et al., 2011).
Another printing-based technology that is important to
mention here, although it always involves cells, is organ
printing. Mironov et al. (2003) defined organ printing as:
’a rapid prototyping computer-aided 3D printing technol-
ogy, based on using layer-by-layer deposition of cell and/
or cell aggregates into a 3D gel with sequential maturation
of the printed construct into perfused and vascularized
living tissue or organ’. The process of organ printing can be
divided into three steps: (a) preprocessing, dealing with the
development of a CAD model for the organ; (b) processing,
the actual layer-by-layer printing of cells or aggregates into
a 3D structure based on the design; and (c) postprocessing,
the perfusion of printed organs and their biomechanical
conditioning to both direct and accelerate organ matura-
tion. A few promising approaches have already shown suc-
cessful fabrication of viable bioprinted osteochondral and
vascularized bone constructs (Fedorovich et al., 2010,
2012b), where cell-laden hydrogels, alone or in combina-
tion with ceramic particles, were used (Fedorovich et al.,
2012a). Further research should aim at understanding the
mechanical stability and bone-forming capacities of these
constructs in vivo in orthotopic defects in large animal
models. While the homogeneous distribution of cells and
the creation of a 3D cellular construct are advantageous,
the organ-printing method has several limitations, includ-
ing the choice of scaffold materials that can be used. In
the case of solid polymers, most scaffold materials need a
strong solvent for dissolution and, hence, printing has been
restricted to hydrogels and thermo-reversible polymers
that lack rigidity (Ringeisen et al., 2006). Furthermore,
the amount of hydrogel that can be printed is rather limited.
Therefore, new formulations with improved mechanical
properties, fast gelation time and versatility to be further
functionalized with biological moieties are needed.
5. Electrospinning
Although RP technologies have improved in terms of reso-
lution, it is still impossible to reproduce features in the
few micrometres-to-submicron range, which would be rele-
vant to mimic the physical properties of native extracellular
matrix (ECM). It is due to this need that electrospinning, a
technique originally developed for the field of textiles and
filtration of aerosols, has become popular with biomedical
researchers. Cooley (1902) and Morton (1902) indepen-
dently patented the method of electrically dispersing fluids
in 1902. Formhals (1934) patented the practical results of
producing silk-like threads, using cellulose-based polymer
solutions in probably the first instance of producing poly-
meric threads using electrical fields. In the late 1930s
Petryanov-Sokolov used electrostatic fields to produce aero-
sol filters and the term ’electrospinning’was first introduced
in publications in the 1990s (Doshi and Reneker, 1995).
The principle of electrospinning is based on the phe-
nomenon that when a sufficiently high voltage is applied
to a liquid droplet, it becomes charged and the electro-
static forces of repulsion counteract the surface tension.
As the intensity of the electric field is increased, the hemi-
spherical surface of the drop is stretched to form a conical
shape, known as a Taylor cone (Taylor, 1969). Once the
strength of the electric field overcomes the surface tension,
a continuous stream of liquid jet is ejected from the Taylor
cone. The charged nature of the jet enables the control of
the trajectory using an electric field. During its flight, the
jet dries and is collected as non-woven fibres on a collector.
Due to the nature of the process, several factors affect the
outcome of the spinning process. Doshi and Reneker
(1995) classified these properties as solution properties,
controlled variables and ambient conditions. Solution prop-
erties include viscosity, conductivity, surface tension,molec-
ular weight and dielectric constant, whereas flow rate,
applied electric field, air gap between needle and collector,
collector geometry and design constitute the controlled var-
iables. Temperature, humidity and air flow are the ambient
parameters that influence the process.
The versatile nature of the process has enabled a range of
different materials, starting from synthetic polymers (e.g.
PCL, PLLA and PEOT/PBT, among others), natural polymers
(e.g. collagen, gelatine, hyaluronate and silk, among others)
and compositematerials to be electrospun. These have found
applications in the engineering of various tissues, such as
skin (Laurencin et al., 2008), cartilage (Li et al., 2005b), bone
(Yoshimoto et al., 2003), blood vessels (Buttafoco et al.,
2005) and nerves (Yang et al., 2005a), as well as in drug
delivery (Ranganath and Wang, 2008). The host of param-
eters that control the process also enables the modification
of fibre texture (Casper et al., 2004; De Vrieze et al., 2009;
Deitzel et al., 2001; Moroni et al., 2006a) (smooth,
rough or porous) and orientation (random or aligned)
(Aviss et al., 2010; Teo and Ramakrishna, 2005).
Electrospun fibres have been used as scaffolds for bone
regeneration in different ways. One of the first electrospun
meshes for this application was fabricated with PCL
(Yoshimoto et al., 2003). Later studies used different poly-
mers, such as PLA (Badami et al., 2006), polyhydroxybutyrate
(PHB) or a polymeric blend such as (poly-3-hydroxy butyrate)-
co-valerate (PHBV) (Sombatmankhong et al., 2007). In
order to improve cell attachment and enhance the biological
capability of the scaffolds, natural polymers such as collagen
(Shih et al., 2006), chitosan (Shin et al., 2005) and silk
fibroin (Meechaisue et al., 2007) were either used as
stand-alone scaffolds or combined with polymers such as
PCL (Ekaputra et al., 2009; Zhang et al., 2005) and PLLA
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(Kim et al., 2008). Additionally, fibres incorporating biolog-
ical factors have been used, either by direct incorporation in
the polymer solution or through co-axial electrospinning (Li
et al., 2006; Su et al., 2012). The resulting scaffolds showed
potential to enhance the differentiation of bone marrow-
derived MSCs. Even more interestingly, Kumar et al.
(2011) showed that simply by tailoring the dimensions of
electrospun polymeric scaffolds in comparison to other
textile scaffolds, it is possible to achieve physical cues able
to directly influence stem cell differentiation.
Bioactive inorganics have also been electrospun into
fibres. Studies have reported the production of different
ceramic fibres, such as HA (Dai and Shivkumar, 2007;
Kim and Kim, 2006; Wu et al., 2004) and fluorinated HA
(Kim and Kim, 2006), using calcium nitrate and triethyl
phosphite as precursor compounds and mixing it with a
polymer such as polyvinyl alcohol (PVA) or polyvinyl butyral
(PVB). After electrospinning, the polymer phase is removed
by calcination. Bioglass fibres with sub-micrometre diameter
were also obtained by mixing the glass with a polymeric
binder (Kim et al., 2006a). Cell viability and osteogenic dif-
ferentiation after seeding rat MSCs were higher on Bioglass
than on electrospun PCL fibres. Sakai et al. (2006)
electrospun ultra-fine silicate fibres and evaluated the pos-
sibility of using them as scaffolds in bone regeneration by
assessing cellular response with human osteoblastic cells
and apatite formation in SBF. Going a step further, compos-
ites of different calcium phosphate ceramics (Jose et al.,
2010; Kim et al., 2006b; Song et al., 2008; Thomas et al.,
2007; Venugopal et al., 2008; Yang et al., 2009) with
synthetic or natural polymers were also electrospun. For
example, Yang et al. (2009) prepared composites of nano-
HAwith PCL, while Kim et al. (2006b) prepared composites
of HAwith PLA using a surfactant. In both studies, compos-
ite fibres showed increased osteogenic differentiation of
cells compared to polymeric scaffolds alone, indicating the
benefits of addingHA to the scaffold. Other studies involved
electrospinning of collagen and HA composites (Song et al.,
2008; Thomas et al., 2007), thereby mimicking the chemi-
cal composition of bone. Aligned multicomponent fibres of
PLGA–collagen and nano-HA were fabricated by varying
the percentage of nano-HA (Jose et al., 2010). The addition
of nano-HA improved mechanical properties at lower con-
centrations, but proved detrimental at amounts> 0.5%.
Preliminary cell data also showed good attachment of
human MSCs on the multicomponent fibres. The challenge
in such an approach is to find a compromise between the
processability of the material and the level of bioactivity
that it possesses.
A strategy used for improving the bioactivity of
electrospun scaffolds for different regenerative applications
while retaining their synthetic character is surfacemodifica-
tion. This is, for example, achieved by plasma or by the
attachment of functional groups (Chen and Su, 2011;
Martins et al., 2009; Park et al., 2007; Prabhakaran et al.,
2008; Xu et al., 2011) in order to control biological phenom-
ena such as cell adhesion and differentiation as a conse-
quence of changes in surface topography, wettability and
chemistry. Treatment methods such as plasma are simple
and inexpensive and can be performed in most laboratories
without the need for complex equipment. The use of inert
and reactive gases, such as argon and oxygen, respectively,
can induce an increase in surface topography and changes
in surface chemistry (e.g. increase in hydroxyl and carbox-
ylic groups). This was shown to be responsible for enhanced
osteoblast adhesion, proliferation and differentiation
(Martins et al., 2009). We have also investigated the use
of oxygen gas plasma to tailor the surface roughness of
PEOT/PBT electrospun scaffolds and showed that a rough-
ness of 10–30nm was associated with a significantly
increased adsorption of proteins from the culture media
and osteogenic differentiation of seeded human MSCs
(Nandakumar et al., 2013b). As an alternative to plasma
treatment, we recently employed nano-imprinting lithogra-
phy to provide electropun fibres with geometrically closely
defined microtopographies, and demonstrated enhance-
ment in cell–material interactions in terms of cytoskeleton
organization. Osteogenic differentiation of hMSCs was also
enhanced upon culture on microgrooved electrospun fibres
as compared to fibres without such grooves (Nandakumar
et al., 2013c). Although recent studies have reported the
potential of controlling cell fate by controlling surface prop-
erties in terms of level of order of topographical features
(McMurray et al., 2011) and their shape (Unadkat et al.,
2011), these technologies have been applied to 2D films,
and their translation to 3D is far from trivial. Modifying sur-
face topography features of electrspun meshes by plasma or
other techniques, as described above, is a first step towards
rendering 3D constructs instructive in a controlled manner.
Electrospinning offers advantages such as ease of use,
fabrication of fibres in the nanometre–micrometre rangewith
different surfaces and alignment, mimicking of the fibrillar
nature of the ECM and spinnability of various materials.
Although these studies inevitably depict the potential of
electrospinning as a scaffold fabrication technology to pro-
duce instructive scaffolds for bone regeneration, electrospun
scaffolds generally lack mechanical properties required for
this application. While a few recent studies (Deng et al.,
2011; Wright et al., 2010) have fabricated 3D electrospun
scaffolds by rolling sheets into cylindrical structures to
achieve structures with compressive moduli in the range of
trabecular bone (lower range 20MPa; Athanasiou et al.,
2000), the use of electrospun scaffolds as stand-alone
supports in compressive load-bearing applications is a major
limitation, as insufficient mechanical support might lead to
excessive deformation, ultimately resulting in failure of
nascent tissue formation (Hollister, 2005). It is possible that
electrospun scaffolds will find a use in non-load-bearing bone
sites, whereas they would have to be combined with more
mechanically rigid structures for weight-bearing applications.
6. Injectables, putties and mouldable
constructs
As mentioned earlier, another requirement from the clinic
that should be taken into consideration when developing
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synthetic 3D alternatives to natural tissue is the possibility
of applying the graft throughminimally invasive surgery, by
facilitating handling, delivery, containment and resistance
to bleeding and irrigation in the defect. This would allow
the treatment of both small and large, critical-sized defects
in a more efficient manner, with less discomfort and infec-
tion risks for the patients and reduced healthcare costs.
Although the scaffold fabrication technologies discussed so
far offer the possibility of customizing the shape, bioactivity
and mechanical properties of the resulting 3D scaffolds for
bone regeneration, the challenge remains to implant them
throughminimally invasive procedures without compromis-
ing bioactivity and mechanical properties. While organic
and inorganic cements have a long history of use in ortho-
paedic and maxillofacial applications, as discussed in vari-
ous reviews (Ambard and Mueninghoff, 2006; Bohner,
2001; Chow, 2009), here we focus on more novel methods
to create non-setting substitutes that preserve their 3D con-
figuration in the defects, i.e. interconnectivity and grain or
granule size optimal for cell and tissue growth. For this pur-
pose, injectable or mouldable systems, i.e. physical blends
of osteoconductive/osteoinductive particulates suspended
in an ‘inert’ gel carrier ensuring the desired rheological
properties, could offer interesting possibilities. In a first
instance, extensive efforts have been put into developing
mouldable or injectable formulations of DBM that basically
consist of autologous or allogeneic bone grafts that have
been deprived of their mineral components, thereby leaving
the natural collagenous ECM, including entrapped growth
factors such as BMP-2 and BMP-7. In a classical approach,
calcium sulphate putties were used to deliver DBM alone
or in combination with bone chips in a canine non-load
bearing orthotopic defect. The injectable system was shown
to restore bone defects after 6weeks (Turner et al., 2003).
Sodium carboxymethylcellulose and poly(ethyleneimine)
were used as carriers for DBM and were shown to maintain
the hydrogel shape over 1month in vitro and in vivo (Kim
et al., 2009); however, to what extent the bioactivity of
DBM is maintained in such a system needs to be further
investigated. Despite these initial promising scientific results
and the development of several commercial injectable
formulations, the combination of DBM with gels does
not solve one of the main drawbacks of DBM, which, being
a natural polymer, is still related to donor-to-donor variabil-
ity, availability and disease transmission (Dinopoulos and
Giannoudis, 2006). To overcome these drawbacks, syn-
thetic inorganics, including calcium phosphate ceramics
and bioglass, have been used as DBM alternatives in inject-
ables and putties. Several inorganic formulations are clini-
cally available in orthopaedics and maxillofacial surgery,
the carrier compositions of which are closely comparable
to those of DBM carriers from both natural and synthetic
origins (e.g. carboxymethylcellulose, collagen, glycerin,
polyethylene glycol, alkylene oxides, fibrin glue, sodium
hyaluronate, collagen) (Bohner, 2010). Furthermore,
putties consisting of carboxymethylcellulose, collagen and,
in some cases, calcium phosphate granules have been con-
sidered as carriers of BMP-7 for clinical use (Cook et al.,
2005; Grauer et al., 2001).
In addition to providing the required handling proper-
ties, the carrier should be biocompatible, resorbable and
not hindering bioactivity in terms of osteoconductivity
and osteoinductivity of the ceramic or bioglass particles.
Barbieri et al. (2011) compared in vivo and in vitro putties
using identical calcium phosphate particles with different
carrier compositions, and established a direct relationship
between carrier resorption kinetics and retention of the
initial osteoinductive potential of the calcium phosphate
particles: the faster the resorption of the carrier, the
better the bone-forming ability of the ceramic particles
is retained. Apart from the rate of degradation, carrier
chemistry and the related resorption mechanism (e.g.
cellular degradation, dissolution) have also an important
role. Davison et al. (2012) compared in vivo two carriers
with identical resorption kinetics, both of which consisted
of one polysaccharide, glycerol and identical TCP gran-
ules. Despite close similarities, the authors showed that
the carboxymethylcellulose–glycerol–TCP carrier allowed
bone formation similar to that of TCP granules alone, in
contrast to the xanthan–glycerol–TCP formulation, where
only a very limited amount of bone was formed. Despite the
rapid resorption of the carboxymethylcellulose–glycerol–TCP
carrier, it was observed that TCP granuleswerewell retained
in a transcortical bone defect after 12weeks of implantation
in a caninemodel, while no traces of xanthan–glycerol–TCP
putty were found after 12weeks of implantation in identical
defects. Therefore the chemistry of the carrier and associ-
ated resorption kinetics and mechanism have a critical role
for retaining the bioactivity of the particulates.
In some studies, it was shown that the preclinical
performance of the carrier/ceramic blends was better than
the performance of ceramic granules alone, suggesting a
positive effect of the carrier on bioactivity (Kania et al.,
1998). In other studies, carrier components were shown
to have a positive, although ancillary, role in bioactivity of
the putty formulations. For example, Cook et al. (2005)
highlighted a positive effect of addition of carboxymethyl-
cellulose into a BMP-7 putty for supporting bone formation
in 2.5-cm osteoperiosteal critical size ulna segmental
defects (Cook et al., 2005), while the implantation of the
same carboxymethylcellulose carrier alone into a rabbit
posterolateral spinal fusion model did not lead to bone
formation (Grauer et al., 2001). Hypotheses attempting to
explain the positive ancillary contribution of the carriers
to the bioactivity of injectable/mouldable formulations are
numerous, as is the number of the existing carriers. Most
of these can be linked to physical aspects, such as shape
retention, defect containment, guidance of cells through
the graft or hydrophilicity, although sometimes direct
biological effects are considered, such as the presence of
biologically active molecules, as in fibrin carrier.
Because putty and injectable configurations are
multicomponent, the industrial development is challeng-
ing in terms of finding sterilization method(s) compatible
to all components, packaging and tools to deliver the graft
to the defect in a ‘ready-to-use’ fashion and the stability of
the putty in time (sterility, handling, osteoinduction/
osteoconduction potential). While DBM, bioactive glasses,
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calcium phosphates and growth factors are prone to
degradation in a humid environment for a prolonged time,
most carriers are water-based gels (Bohner, 2010; Kanayama
et al., 2006). Using such water-based gels in ‘ready-to-use’
configurations can be detrimental to the initial specifications
of the osteoinductive/osteoconductive biomaterial (Davison
et al., 2012; Schmitt et al., 2002) and subsequently to perfor-
mance in bone regeneration. As a consequence, several clin-
ical formulations are provided in separate vials to be mixed
in the operating suite prior to application in the patient
(Bohner, 2010; Kanayama et al., 2006), increasing the risks
of infection or inadequate preparation or dosage. To over-
come this bottleneck, one of the novel advances is formula-
tions based on water-free putties, ensuring the retention of
bioactivity of the bone graft substitute (Davison et al.,
2012). This initial work on water-free carriers combined
with calcium phosphate granules can be translated to other
osteoinductive/osteoconductive biomaterials or molecules,
such as DBM, BMPs or bioglasses, for a truly ‘plug-and-
play’ bone graft system.
Despite these advances in the engineering of injectable
and mouldable synthetic formulations, these systems still
suffer from poor mechanical properties that are far from
matching those of trabecular or cortical bone, making this
an intrinsic drawback so far in all such injectable systems
for minimally invasive surgeries for bone repair.
7. Combining technologies to create
improved scaffolds
As described in previous sections, different techniques
exist to build 3D constructs from a variety of biomaterials,
each with its advantages and disadvantages. Just like
different materials can be combined into one construct,
to exploit intrinsic positive properties of each of them,
combining different scaffolding technologies to build
these constructs is an interesting approach. For example,
a combination of RP and ESP techniques could result in
a scaffold that is mechanically suitable for use in ortho-
paedic applications and still contains micro-/nano-scale
functionality, due to the presence of ECM-like fibres.
Vaquette et al. (2012) used this approach to create a scaf-
fold for the regeneration of alveolar bone and periodontal
ligament, where the RP scaffold was used as a bone com-
partment and the ESP mesh for the regeneration of the
ligament. The resulting scaffold supported bone formation
as well as ligament tissue formation. Furthermore, the inte-
gration of the two scaffolding technologies was also corre-
lated with the improved attachment of the scaffold to the
dentine layer apposed to the construct in a subcutaneous
rat implantation model. Similarly, we combined different RP
technologies to create osteochondral scaffolds with mechan-
ical, structural and physicochemical properties matching
those of articular cartilage and subchondral bone. The
resulting scaffolds showed to support osteochondral tissue
formation when seeded with MSCs and implanted subcuta-
neously in nude mice for 1month (Moroni et al., 2008).
Conventional ways of producing ceramic–polymer com-
posites include the use of blends of the two as a starting
material for scaffold fabrication. In our recent study, we
have compared such monolithic scaffolds produced by
3DF deposition of a polymer–ceramic blend, to scaffolds
with comparable architecture with distinct polymeric and
ceramic phase. The latter scaffold was prepared by build-
ing polymeric scaffolds using 3DF deposition, into the
pores of which particles of the ceramic were press-fit
inserted (Figure 3). The differences between these mono-
lithic and assembled constructs lay in both the mechanical
properties and the availability of calcium phosphate to
the environment, which has consequences for biological
Figure 3. Scanning electron microscopy shows different examples of scaffold fabrication technology integration. Electrospinning
and additive manufacturing can be combined to create scaffolds with macro-, micro- and nanoscaled fibre dimensions (A, B). These
fibres can be further functionalized by calcium phosphate-based coatings (C). Alternatively, ceramic particles of customized dimen-
sions (D, E) and microstructure (F) can be designed to fit within the pores of an RP scaffold, resulting in an alternative strategy to
create composite scaffolds
754 L. Moroni et al.
Copyright © 2013 John Wiley & Sons, Ltd. J Tissue Eng Regen Med 2015; 9: 745–759.
DOI: 10.1002/term
performance, while the ratio of the two material types
remained the same in both approaches (Nandakumar
et al., 2013a). Furthermore, by varying the geometry of
the ceramic particles introduced in the polymeric matrix
and the amount and position of these particles in the pores
of the matrix, the stress and strain at break, as well as the
compressive and bending modulus, could be tailored
(Moroni et al., 2008). A similar approach was earlier used
by Li et al. (2007) to build constructs consisting of a ceramic
core, made by a conventional porogen-based technique, and
a titanium alloy shell produced by RP in an attempt to retain
the mechanical properties of the metal as well as the bioac-
tivity of the ceramic. This study indeed showed more bone
formation in constructs containing the ceramic core as com-
pared to metallic scaffolds. With the aim of regenerating
complex tissues affected by periodontal disease, Carlo Reis
et al. (2011) developed a semi-rigid bilayered PLGA–CaP
construct, consisting of a porous inner structure and a
continuous outer membrane. The porous core was pro-
duced by combining a classical solvent-based method for
preparing a polymer–ceramic composite, followed by
porogen leaching and coating with a thin layer of the
second CaP phase, using immersion in an aqueous solution,
while the continuous membrane was produced by casting
of the composite solution. The authors observed new
cementum, bone and periodontal ligament formation
with Sharpey fibre insertions upon implantation of these
bilayered constructs in class II furcation defects in dogs, in
contrast to a control group (Carlo Reis et al., 2011). Similar
porous composite constructs, without the continuous mem-
brane, were used for either augmentation or preservation of
alveolar bone height upon tooth extraction in a clinical trial
(Davies et al., 2010).
Considering that bioactivity of calcium phosphate
ceramics is suggested to lie in dynamic processes of disso-
lution/reprecipitation occurring on the surface, availabil-
ity of the surface to the biological environment is of
importance. Coating 3D structures of different materials
with a thin layer of calcium phosphate is a relatively sim-
ple approach to add bioactivity to materials such as metals
and coatings. This strategy has been widely exploited to
improve osteointegration between metallic hip implants
and the surrounding bone (Havelin et al., 2000). While
plasma spraying is generally accepted as a successful
method for coating metallic implants, this line-of-sight
process, which takes place at very high temperatures, is
not suitable for coating polymers or for depositing ther-
mally unstable calcium phosphate phases, and it cannot
be applied to geometrically complex porous 3D shapes.
Several other methods have also been used for coating sub-
strates with calcium phosphate. These include sol–gel coat-
ings (Kim et al., 2004), pulsed laser deposition (Cleries et al.,
2000), radio-frequency sputtering (Yang et al., 2005b) and
electrochemical methods (Kumar et al., 1999). In the
1990s, Kokubo and co-workers developed mineralizing
solutions based on physiological fluids (Abe et al., 1990;
Kokubo et al., 1990) that could be used to deposit apatitic
layers on various substrates at near-physiological tempera-
ture and pH. This biomimetic coating method offers several
advantages, such as coating of temperature-sensitive sub-
strates such as polymers (Du et al., 2002b), formation of
phases other than HA, such as carbonated apatite and
octacalcium phosphate (OCP) (Leeuwenburgh et al., 2001),
and deposition on porous and complex geometric shapes.
Barrere et al. (2002a, 2002b)modified the initial biomimetic
coating process by using a supersaturated SBF to increase
the speed of the coating process to coat titanium-based sub-
strates. Recently, such a coating process has also been used
to coat other substrates, such as spider silk (Yang et al.,
2010), and synthetic polymeric 3D scaffolds made using
conventional (Carlo Reis et al., 2011; Davies et al., 2010;
Du et al., 2002a), RP (Oliveira et al., 2009; Yuan et al.,
2001), ESP (Yang et al., 2008) and combined RP+ESP
techniques (Figure 3).
8. Conclusion and future perspectives
In order to exploit the power of various available technol-
ogies to a greater extent, combining or integrating them
when fabricating a single scaffold clearly offers new
opportunities. Advances in additive manufacturing tech-
nologies will likely deliver to the scientific and clinical
communities 3D constructs with an increasing degree of
complexity. In our view, it is not too optimistic to envision
the fabrication of a 3D structure displaying a perfect copy
of osteons arrangement and, in parallel, controlling in
space and time mechanical, physical, chemical and biolog-
ical cues with an exquisite precision to mimic a targeted
bone segment to regenerate. A key question to answer in
the immediate future is to what extent we need to achieve
this in vitro or in vivo. Even from a clinical translation
perspective, a relevant question that will need to be
answered is to what extent we need to follow biomimicry
approaches at all, if this complicates the path from the
bench to the bedside without an appreciable and sensible
improvement in the regeneration of critical-sized bone
defects. Nevertheless, biomimicry approaches will surely
be useful to obtain 3D in vitro models to study bone-
related pathologies and screen new medical treatments.
Such screens, in turn, have the potential to increase the
speed at which the synthetic bone graft substitutes are
developed. Therefore, the efforts of engineers to advance
the existing technologies and their combinations in order
to provide biologists and clinicians with suitable plug-and-
play systems is justified, as this will, directly or indirectly,
contribute to the improvement of the life quality of patients
with musculoskeletal conditions.
Another challenge, for which we expect to see tremen-
dous efforts in the near future, is to design and engineer
materials able to control biological processes such as cell fate
and tissue formationwithout losing their synthetic character.
In particular, development of methods applicable to 3D,
functional synthetic implants, that allow temporal and/or
spatial control over in vivo processes related to bone regener-
ation and remodelling, will be challenging but promise an
enormous gain for the field of regenerative medicine.
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